1Yamada Y,Post SR,Wang K,et al.Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain,gastrointestinal tract,and kidney[J].Proc Natl Acad Sci USA,1992,89:251-255.
2Patel YC.Somatostatin and its receptor family[J].Front Neuroendocrinol,1999,20:157-198.
3Reubi JC,Kvols L,Krenning E,et al.Distribution of somatostatin receptors in normal and tumor tissue[J].Metabolism,1990,39(9 Suppl 2):78-81.
4Reubi JC,Waser B,Horisberger U,et al.In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue[J].Blood,1993,82:2143-2151.
5Bousquet C,Puente E,Buscail L,et al.Antiproliferation effect of somatostatin and analogs[J].Chemotherapy,2001,47(Suppl 2):30-39.
7Hofland LJ,van der Hoek J,Feelders R,et al.Pre-clinical and clinical experiences with novel somatostatin ligands:advantages,disadvantages and new prospects[J].J Endocrinol Invest,2005,28(11 Suppl):36-42.
8Teunissen JJ,Kwekkeboom DJ,Krenning EP.Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs[J].Trends Endocrinol Metab,2006,17:19-25.
9Jaquet P,Saveanu A,Barlier A.New SRIF analogs in the control of human pituitary adenomas:perspectives[J].J Endocrinol Invest,2005,28(5 Suppl):14-18.
10Grant MB,Caballero SJ.The potential role of octreotide in the treatment of diabetic retinopathy[J].Treat Endocrinol,2005,4:199-203.
